Quercetin in cancer prevention and therapy

Integrative Cancer Therapies

Volumn 12, Issue 2, 2013, Pages 97-102

  Chirumbolo, Salvatore ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Cancer; Flavonoids; NF B; Quercetin; Signaling

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; I KAPPA B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; QUERCETIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CHEMOPROPHYLAXIS; HUMAN; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CHEMOPREVENTION; FLAVONOIDS; HUMANS; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; QUERCETIN; SIGNAL TRANSDUCTION;

EID: 84877812825     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735412448215     Document Type: Article

References (50)

1. Chirumbolo S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets. 2010;9: 263-285.
2. Gibellini L, Pinti M, Nasi M, et al. Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med. 2011;2011:591356.
3. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585: 325-327.
4. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26: 1001-1043.
5. He SM, Li CG, Liu JP, Chan E, Duan W, Zhou SF. Disposition pathways and pharmacokinetics of herbal medicines in humans. Curr Med Chem. 2010;17: 4072-4113.
6. Nair HB, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, Aggarwal BB. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol. 2010;80: 1833-1843.
7. Bischoff SC. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care. 2008;11: 733-740.
8. Vargas AJ, Burd R. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev. 2010;68: 418-428.
9. Bremner P, Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol. 2002;54: 453-472.
10. Nam NH. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem. 2006;6: 945-951.
11. Min YD, Choi CH, Bark H, et al. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res. 2007;56: 210-215.
12. Perkins ND. Integrating cell signaling pathways with NF-κB and IKK function. Nature 2007;8: 49-62.
13. Hishikawa K, Nakaki T. NF-kappa B as a therapeutic drug target [in Japanese]. Nihon Yakurigaku Zasshi. 2001; 118: 197-202.
14. Schneider G, Krämer OH. NFκB/p53 crosstalk-a promising new therapeutic target. Biochim Biophys Acta. 2011; 1815: 90-103.
15. Chen JC, Ho FM, Pei-Dawn Lee Chao, et al. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol. 2005;521: 9-20.
16. Kim YH, Lee YJ. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. J Cell Biochem. 2007;100: 998-1009.
17. Wang K, Liu R, Li J, et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTORand hypoxia-induced factor 1α-mediated signaling. Autophagy. 2011;7: 966-978.
18. Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010;29: 405-434.
19. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002;2: 594-604.
20. Thangasamy T, Sittadjody S, Limesand KH, Burd R. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine. Cell Oncol. 2008;30: 371-387.
21. Vargas AJ, Sittadjody S, Thangasamy T, Mendoza EE, Limesand KH, Burd R. Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53. Integr Cancer Ther. 2011;10: 328-340.
22. Sun ZJ, Chen G, Hu X, et al. Activation of PI3K/Akt/IKK-alpha/ NF-kappaB signaling pathway is required for the apoptosisevasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis. 2010;15: 850-863.
23. Kong D, Zhang Y, Yamori T, Duan H, Jin M. Inhibitory activity of flavonoids against class I phosphatidylinositol 3-kinase isoforms. Molecules. 2011;16: 5159-5167.
24. Hou DX, Kumamoto T. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxid Redox Signal. 2010;13: 691-719.
25. Hwang MK, Song NR, Kang NJ, Lee KW, Lee HJ. Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase- 9: its direct inhibition by quercetin. Int J Biochem Cell Biol. 2009;41: 1592-1600.
26. Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals. J Cell Physiol. 2012;227: 1891-1898.
27. Benbrook MD, Masamha PC. The pro-survival function of Akt kinase can be overridden or altered to contribute to induction of apoptosis. Curr Cancer Drug Targets. 2011;11: 586-599.
28. Gulati N, Harter D, Desai D, Amin S, Murali R, Jhanwar- Uniyal M. Quercetin inhibits the akt pathway, leading to suppression of survival and induction of apoptosis in cancer cells. Proc Am Assoc Cancer Res. 2005;46:Abs 2281.
29. Walker EH, Pacold ME, Perisic O, et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell. 2000;6: 909-919.
30. Chirumbolo S, Marzotto M, Conforti A, Vella A, Ortolani R, Bellavite P. Bimodal action of the flavonoid quercetin on basophil function: an investigation of the putative biochemical targets. Clin Mol Allergy. 2010;8: 13-25.
31. Xavier CP, Lima CF, Preto A, Seruca R, Fernandes-Ferreira M, Pereira-Wilson C. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Lett. 2009;281: 162-170.
32. Krześlak A. Akt kinase: a key regulator of metabolism and progression of tumors [in Polish]. Postepy Hig Med Dosw (Online). 2010;64: 490-503.
33. Carnero A. The PKB/AKT pathway in cancer. Curr Pharm Des. 2010;16(1): 34-44.
34. Jiang BH, Liu LZ. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta. 2008;1784(1): 150-158.
35. Hu MC, Hung MC. Role of IKβ kinase in tumorigenesis. Future Oncol. 2005;1: 67-78.
36. Wu LC, Lu IW, Chung CF, Wu HY, Liu YT. Antiproliferative mechanisms of quercetin in rat activated hepatic stellate cells. Food Funct. 2011;2: 204-212.
37. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-κB in p53-mediated programmed cell death. Nature. 2000; 404: 892-897.
38. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol. 2010;649: 84-91.
39. Tanigawa S, Fujii M, Hou DX. Stabilization of p53 is involved in quercetin induced cell cycle arrest and apoptosis in HepG2 cells. Biosci Biotechnol. Biochem. 2008;72: 797-804.
40. Ougolkov AV, Billadeau DD. Targeting GSK-3: a promising approach for cancer therapy? Future Oncol. 2006;2: 91-100.
41. Deng J, Xia W, Miller SA, Wen Y, Wang HY, Hung MC. Crossregulation of NF-kappaB by the APC/GSK-3beta/betacatenin pathway. Mol Carcinog. 2004;39: 139-146.
42. De Mejia EG, Dia VP. The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells. Cancer Metastasis Rev. 2010;29: 511-528.
43. Van der Hoeven JC, Bruggeman IM, Debets FM. Genotoxicity of quercetin in cultured mammalian cells. Mutat Res. 1984;136: 9-22.
44. Rutkowski R, Hofmann K, Gartner A. Phylogeny and function of the invertebrate p53 superfamily. Cold Spring Harb Perspect Biol. 2010;2(7):a001131.
45. Farnebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun. 2010;396: 85-89.
46. Chen F, Wang W, El-Deiry WS. Current strategies to target p53 in cancer. Biochem Pharmacol. 2010;80: 724-730.
47. Lewis-Wambi JS, Jordan VC. Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res. 2009;11:206.
48. Song RX, Santen RJ. Apoptotic action of estrogen. Apoptosis. 2003;8: 55-60.
49. Shanmugam MK, Kannaiyan R, Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer. 2011;63: 161-173.
50. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397-1421.